← signals
2026-08-09·AAPL·ai edge hardware
lowup

A Manifold market shows 77.34% consensus that Apple will release an AI chip for iPhones in 2026.

A Manifold market shows 77.34% consensus that Apple will release an AI chip for iPhones in 2026.

window 90devidence 2confidence score 73price AAPL $308.26

confidence score

Usable evidence: enough corroboration to publish, with 1 independent source class.

73
low confidence1 independent source classesmarketpasses publish gate
priced-in check

AAPL has not made a large direction-matching 30-90 day move yet.

not priced in
as of 2026-08-107d n/a45d n/a90d +5%yahoo

signal brief

A Manifold market shows 77.34% consensus that Apple will release an AI chip for iPhones in 2026. This signals that the market broadly expects Apple to bring on-device AI silicon to the iPhone, potentially a dedicated neural engine or AI coprocessor built on TSMC's advanced nodes. Such a move would accelerate edge AI adoption and likely increase per-device silicon content, benefiting Apple's differentiation and TSMC's capacity bookings. A secondary market in the same batch asked whether any four of eight major tech names would lose 60% of peak value before 2028, with a 20.73% YES probability — that tail risk is not the core signal but adds context to the AI hardware race. The bull case is clear: an Apple-designed AI chip could drive a supercycle of iPhone upgrades and strengthen Apple's position in on-device inference. The bear case: the 2026 timeline may slip, the "AI chip" could be a minor component rather than a bespoke SoC, and prediction markets are not authoritative. Direction is up for Apple and TSMC, with low confidence given the reliance on a single speculative source.

What the sources said

  • "Will Apple release an AI chip for iPhones in 2026? — YES=77.34%" (source)
  • "Will any 4 of AAPL, AMZN, ASML, GOOG, META, MSFT, NVDA, and TSM lose 60% of their peak value before 2028? — YES=20.73%" (source)

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.